Big pharma approach to drug R&D challenged by UN panel

Report's authors call for a de-linkage of R&D costs and drug prices — at least in areas where the system is failing, such as tropical diseases and the hunt for new antibiotics against "superbug" resistant bacteria.

from CBC | Health News http://ift.tt/2cZVrVh